Skip to main content

Peer Review reports

From: Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus

Original Submission
13 Nov 2018 Submitted Original manuscript
24 Jun 2019 Author responded Author comments - Timothy Robert McGuire
8 Dec 2018 Reviewed Reviewer Report - Carmen Balana
14 Dec 2018 Reviewed Reviewer Report - Barbara Marengo
Resubmission - Version 2
24 Jun 2019 Submitted Manuscript version 2
9 Aug 2019 Author responded Author comments - Timothy Robert McGuire
Resubmission - Version 3
9 Aug 2019 Submitted Manuscript version 3
Publishing
13 Aug 2019 Editorially accepted
27 Aug 2019 Article published 10.1186/s12885-019-6033-2

You can find further information about peer review here.

Back to article page
\